The White House has finally released a plan to address drug shortages, linking Medicare payments to hospitals with practices that prevent shortages. A task force was formed in early 2023 to tackle the issue, particularly with cancer drugs shortages. Lawmakers have not been in contact with the task force and are unsure of its leadership. Several proposals in Congress aim to fix the problem, including improving drug manufacturing, encouraging domestic production, incentivizing hospitals to purchase from generic drug manufacturers with reliable supply chains, and allowing generic drugmakers to charge higher prices. The proposals lack cohesion and a unified approach to solving the issue.
Source link
White House offers new plan to address drug shortages
